Life-saving SMA medicine to be made available to Australian babies
Access to a life-saving and life-changing medicine will soon be expanded for Australian children and infants with Spinal Muscular Atrophy (SMA). From 1 December, subsidised access to the life-changing medicine Spinraza® (nusinersen) will be expanded on the Pharmaceutical Benefits Scheme (PBS). It will include children and infants genetically diagnosed with the most severe types…